MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hopfinger, A. J.
Right arrow Articles by Potenzone, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hopfinger, A. J.
Right arrow Articles by Potenzone, R

Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis

AJ Hopfinger and R Potenzone

A quantitative structure-activity relationship (QSAR) based upon molecular shape analysis has been developed for a set of 18 1-(X- phenyl)-3,3-dialkyltriazenes for which mutagenic potency is reported. An "active" molecular shape is proposed which suggests, in turn, a self- consistent mechanism for the microsomal hydroxylation of the nitrogen methyl group. A second QSAR has been constructed for an alternate set of 24 1-(X-phenyl)-3,3-dialkyltriazenes for which antitumor potency is reported. The QSAR suggests that the "active shape for antitumor potency is the same as that hypothesized for Ames mutagenic potency. A QSAR for a therapeutic index (TI) has been constructed to allow optimization of the difference between antitumor and mutagenic potencies. Large TIs require substituents on position 3 of the phenyl ring which are hydrophilic. The antitumor QSAR has been applied to three known compounds to test its reliability. A compound is predicted that is expected to have high antitumor activity and low mutagenicity. An overview of the methodology of molecular shape analysis, and its limitations, is included as part of this report on the development of QSARs.

Volume 21, Issue 1, pp. 187-195, 01/01/1982
Copyright © 1982 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1982 by the American Society for Pharmacology and Experimental Therapeutics